VRNA β€” VERONA PHARMA PLC

Ownership history in UBS Group AG  Β·  24 quarters on record

This page tracks every 13F SEC filing in which UBS Group AG reported a position in VERONA PHARMA PLC (VRNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.02% (2025 Q2)
πŸ“Š Avg. % of fund
0.0%
πŸ“… First filed
2018 Q1
πŸ“… Last filed
2025 Q3
⏱ Quarters held
24
% of Fund (quarterly)
πŸ“‹ Quarterly Holdings History 10 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 89,887 -1,096,294 -92.4% 0.00% $9.6M β€”
2025 Q2 ADDED 1,186,181 +923,327 +351.3% 0.02% $112.2M β€”
2025 Q1 REDUCED 262,854 -110,551 -29.6% 0.00% $16.7M β€”
2024 Q4 ADDED 373,405 +238,837 +177.5% 0.00% $17.3M β€”
2024 Q3 ADDED 134,568 +31,689 +30.8% 0.00% $3.9M β€”
2024 Q2 ADDED 102,879 +101,044 +5506.5% 0.00% $1.5M β€”
2024 Q1 REDUCED 1,835 -179 -8.9% 0.00% $30K β€”
2023 Q4 REDUCED 2,014 -1,323 -39.6% 0.00% $40K β€”
2023 Q3 ADDED 3,337 +332 +11.0% 0.00% $54K β€”
2023 Q2 REDUCED 3,005 -2,427 -44.7% 0.00% $64K β€”
14 older quarters hidden  β€”  Sign in free or upgrade to Premium to see full history

🏒 Other funds also holding VRNA

As of 2025 Q3 β€” sorted by position size

SYQUANT CAPITAL SAS 3Y 37.01% Twin Securities, Inc. 3Y 7Y 26.58% Vazirani Asset Management LLC 3Y 22.88% Aisling Capital Management LP 3Y 7Y 14.39% NEA Management Company, LLC 3Y 7Y 13.19% OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3Y 7Y 12.73% Chicago Capital Management, LLC 3Y 7Y 12.37% Vivo Capital, LLC 3Y 7Y 11.97% KRYGER CAPITAL Ltd 3Y 11.86% GLAZER CAPITAL, LLC 3Y 7Y 11.48%
← Back to UBS Group AG Holdings